« Five Neurodevice Startups Target the Brain |
| Neurotech Leaders Forum 2005 Conference Review »
October 23, 2005
Cutting Edge Neurodevice Technologies - MCS and TMS
Warren Grill highlighted two areas:
-Motor Cortex Stimulation (MCS) to treat Parkinson's is showing promise in animal models. MCS normalizes rate and pattern of basal ganglia neurons in primates. This week in Neurosurgery an article showed that stimulation appeared to reduce amount of L-Dopa needed.
-TMS (transcranial magnetic stimulation) for migraine headache from Neuralieve looks interesting. The concept is that prior to onset of a migraine a lot of people get an aura, so when people get this feeling that stimulate their cortex with 2 pulses, 5 seconds apart. Neuralieve was founded by the same people who founded NeuroPace.
John Mcdonald, Director of the Spinal Cord Injury Institute spoke about Restorative Therapies' Activity Based Restoration program.
MindCare Centres opended first rTMS clinics for depression. What is rTMS? Repetitive Transcranial Magnetic Stimulation is a computer controlled magnetic beam applied 20 minutes a day that is non-invasive with minimal/or no side effects. No accidental seizures since 1996. rTMS may apply to many treatment resistant patients in the following markets: depression, anxiety, PTSD, OCD, tinnitus, pain, Parkinson's, migraines, aphasia, stroke (right after event), eating disorders, addiction.
+ TrackBacks (0) | Category: Neurodevices
- RELATED ENTRIES
- Chinese Cover of The Neuro Revolution
- The Neuro Revolution Lands In China
- How Neuroscience Will Change the World - My Interview on Reason.tv
- Neuroscience Hearing on Capitol Hill Wednesday Sept 29, 2pm
- The Neuro Revolution Published in Japan as "Neuro Wars"
- Neurotech 2010: Translational Researchers Highlight Innovation
- The Neuro Revolution in China Progressing
- Speakers for Neurotech 2010 - Boston, May 19-20